In it for patients

Our vision is to improve the lives of people with cancer through innovative targeted therapies.

Who we are

Seagen is a global biotechnology company dedicated to revolutionising cancer care. We’re developing transformative therapies that make a meaningful difference in people’s lives.

Our science

As a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for more than 20 years. We’re committed to discovering effective solutions to challenging clinical needs. Today, our research efforts are dedicated to advancing a pipeline of innovative therapies for solid tumours and blood-related cancers.

Contact us / Site publisher

Seagen U.K. Ltd.

The Charter Building
Charter Place
Uxbridge UB8 1JG
UK

Email: OfficeUK@seagen.com

Medical Information and Safety
To report an adverse event or request additional information about our medicines, please contact our Medical Information team via email MedInfoEU@seagen.com or alternatively call (+44) 330 818 0490. Our Medical Information team is available from Monday to Friday from 9am to 5pm GMT.

For Customer Service in England/Scotland/Wales (product order or customer registration enquiries) contact

(+44) 152 521 6650

seagen@polarspeed.com

The Customer Service team is available from Monday to Friday from 8:30 a.m. to 5:00 p.m. GMT

For Customer Service in Northern Ireland (product order or customer registration enquiries) contact

(+49) 5241 9919 2280

seagen@arvato-scs.com

The Customer Service team is available from Monday to Friday from 7:30 a.m. to 4:00 p.m. GMT

Companies House Registry 06321958 - VAT GB355368868

Job Code UK/COR/2023/0005